CN1186679A - Medicine for curing pulmonary tuberculosis - Google Patents
Medicine for curing pulmonary tuberculosis Download PDFInfo
- Publication number
- CN1186679A CN1186679A CN96121466A CN96121466A CN1186679A CN 1186679 A CN1186679 A CN 1186679A CN 96121466 A CN96121466 A CN 96121466A CN 96121466 A CN96121466 A CN 96121466A CN 1186679 A CN1186679 A CN 1186679A
- Authority
- CN
- China
- Prior art keywords
- powder
- pulmonary tuberculosis
- medicine
- radix
- angelicae dahuricae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The medicine consists of powder of six Chinese medicinal materials including notoginseng, lily, Radix Angelica Dahurica, Solanum lyratum, date rind, etc, and it is prepared through pulverizing, sieving and mixing. It is prepared in various preparation forms, ointment, capsule, etc., by compounding with animal fat and sugar. It has obvious cure effect to pulmonary tuberculosis.
Description
The present invention relates to the sick Chinese medicine of treatment pulmonary tuberculosis (pulmonary tuberculosis).
Pulmonary tuberculosis (pulmonary tuberculosis) disease is the healthy a kind of communicate illnesss of a kind of people of harm.It can pass through multiple channels such as breathing, food and infect pathogenic.Once catching this disease, be easy to infect other people.Doctor trained in Western medicine circle all adopts intramuscular injection, infuses and takes this disease of oral drug therapy both at home and abroad at present.Though certain curative effect is arranged, all toxic side effect or side reactions after the medication.A disease does not heal often, and he becomes renvoi by diease occurrence.As rifampicin medicine, just liver, kidney there is damage.Use antibiotic medicine also can make auditory dysesthesia chronically, even cause deafness to be become deaf.Middle medical circles are then many based on decoction, and its curative effect is also undesirable.Therefore, China reaches 15% because of its sick mortality rate.
The object of the present invention is to provide the sick Chinese medicine of a kind of treatment pulmonary tuberculosis (pulmonary tuberculosis).
Technical scheme of the present invention is as follows:
The present invention is made up of Chinese medicinal powder buckwheat Radix Notoginseng, Chinese medicinal powder Bulbus Lilii, the Chinese medicinal powder Radix Angelicae Dahuricae, Chinese medicinal powder Herba Solani Lyrati, Chinese medicinal powder Fructus Corni, Chinese medicinal powder Radix Actinodaphnes Cupularis, and its percentage by weight accounts for respectively:
Buckwheat Radix Notoginseng: 60%
Bulbus Lilii: 15.5%
The Radix Angelicae Dahuricae: 2%
Herba Solani Lyrati: 13.5%
Fructus Corni: 6%
Radix Actinodaphnes Cupularis: 3%
Total weight percent: 100%
Herbal powder buckwheat Radix Notoginseng, powder Bulbus Lilii, the powder Radix Angelicae Dahuricae, powder Herba Solani Lyrati, powder Fructus Corni, powder Radix Actinodaphnes Cupularis Six-element Chinese herbal medicine are 200 orders~220 orders.
Make ointment after also can mixing with Animal fat and saccharide.
Its accessory formula is: in per 4000 gram medicine powders:
Mel: 1000g, crystal sugar: 1000g, white sugar 1000g, change Adeps Sus domestica 1000g, Pancreas Sus domestica (bright product): 21 pairs.
If the person that do not eat Carnis Sus domestica because of national custom is different, can removing Adeps Sus domestica and Pancreas Sus domestica, with Adeps caprae seu ovis, Pancreas caprae seu ovis replacement.
The present invention collects clinical experience for many years, by selecting natural Chinese medicinal herb for use in motherland's medical treasure-house.The foster Radix Notoginseng Chinese medicine of selecting for use: cold flat, little acid, suffering, sweetness and bitterness, its effect: spleen invigorating regulate the flow of vital energy, cool down eliminate indigestion, eliminating stasis to stop pain, sterilization detumescence, control pain in the lung, control lump in the abdomen.
Bulbus Lilii: sweet, hot, nontoxic, its effect: control that pathogen abdominal distention is pained, invigorating vital QI, feel at ease to decide the gallbladder Fructus Alpiniae Oxyphyllae, support the five internal organs, control that all skin ulcers of mastalgia carbuncle on the back are swollen, warming the lung to relieve cough.
Radix Angelicae Dahuricae: hot, temperature, nontoxic, its effect: treat ailment said due to cold or exposure, removing blood stasis, benefit fresh blood, pain relieving evacuation of pus, treat new pain, carbuncle on the back scrofula, sharp YANG MING headache, apoplexy cold and heat and wind and heat in the lung meridian.
Herba Solani Lyrati: sweet, cold, nontoxic, its effect: control cold and heat eight subcutaneous ulcers, quench one's thirst, invigorating the spleen and replenishing QI, clothes are made light of one's life by commiting suicide and prolonged life for a long time, make the thick soup drink and very treat consumptive disease.
Fructus Corni: acid, hot, nontoxic, its effect: remove three worms, settling five organs, add marrow, reinforcing YIN-essence supports intelligence, the kidney invigorating gas.
Radix Actinodaphnes Cupularis: cold, nontoxic, its effect: press, go three worms under haematemesis, epistaxis, the hemorrhoidal hamorrhage.
Processing technology process of the present invention is as follows:
Select materials → mill → sieve → wine made of broomcorn millet material → aseptic process → feed → seal → finished product packing → market.
Buckwheat Radix Notoginseng, the Bulbus Lilii Radix Angelicae Dahuricae, Herba Solani Lyrati, Fructus Corni, Radix Actinodaphnes Cupularis Six-element Chinese medicine are carried out selected tanning by the sun afterwards, be milled into powder again, sieve with 200 orders~220 mesh sieve, extracting screen underflow is prepared burden then, its percentage by weight accounts for respectively: buckwheat Radix Notoginseng 60%, Bulbus Lilii 15.5%, the Radix Angelicae Dahuricae 2%, Herba Solani Lyrati 13.5%, Fructus Corni 6%, Radix Actinodaphnes Cupularis 3%, total weight percent: 100%.Will be above-mentioned six medicaments add adjuvant after mixing again: its adjuvant is by Mel, crystal sugar, white sugar, change Adeps Sus domestica, Pancreas Sus domestica, if because of the national custom person that do not eat Carnis Sus domestica, then with Adeps caprae seu ovis, Pancreas caprae seu ovis alternativeization Adeps Sus domestica, Pancreas Sus domestica respectively.It is filled a prescription in per 4000 gram hybrid medicines, must add Mel: 1000g, crystal sugar: 1000g, white sugar 1000g, change Adeps Sus domestica 1000g, Pancreas Sus domestica (bright product): 21 pairs are made ointment, in the vial that carries out again packing into after the high-temperature sterilization or the interior seal package of tinned type move towards market behind the finished product.
Advantage of the present invention is as follows:
1. dosing is little, and only obey once every day, only obeys the 100g ointment at every turn.
2. curative effect height, short treating period: one month is a course of treatment, and light patient can fully recover two courses of treatment, and heavy patient can fully recover three courses of treatment.
3. the present invention is made up of pure Chinese herbal medicine and pluck, and is without any side effects, and appetite and body weight all can increase after generally taking medicine 40 days.
4. taking convenience is in the man, journey is medium all can take.
5. exempt the traditional therapy of the necessary hospitalization of treatment pulmonary tuberculosis, alleviated patient's financial burden.
6. the multiple pill tablet of intramuscular injection, transfusion, clothes etc. of having exempted present treatment pulmonary tuberculosis is to the discomfort of the intestines and stomach and to the damage or the side effect of organs such as liver, kidney, stomach.
In conjunction with the embodiments, the present invention is further illustrated:
1. the preparation of the ointment of treatment pulmonary tuberculosis (pulmonary tuberculosis) disease:
The buckwheat Radix Notoginseng of choice of powder shape: 2400g, Bulbus Lilii 620g, Radix Angelicae Dahuricae 80g, Herba Solani Lyrati: 540g, Fructus Corni: 240g, Radix Actinodaphnes Cupularis: 120g, after mixing, become the medicine of 4000g, add Mel: 1000g, crystal sugar: 1000g, white sugar 1000g, change Adeps Sus domestica 1000g, Pancreas Sus domestica (bright product) again: 21 submodulation become ointment, with 100g vial this ointment of packing into, be the medicine of taking of three courses of treatment an of patient.
2. demonstrate effect of the present invention below:
(1). the king * *, the man, 56 years old, Miao Ping Qu Miao level ground, Jianshi County village 16 peasants of the production team checked typing: pulmonary tuberculosis through the People's Hospital, Jianshi County, there is not big curative effect from 65 year Mays in March to 67 in this institute's treatment, its symptom is: haematemesis piece, cough and with asthma, take this medicine after five months in April, 69 to August, through X-ray examination, two lungs are clear, and symptom 100% disappears.
(2). Tang * *, man, 36 years old, principal in the long deck-molding in Jianshi, when studying in middle school, because of with the infected hectic disease of classmate's coordination of a hectic, normal hemoptysis, and often tell sedan-chair, nineteen fifty-nine to 1977 year, interrupted treatment is 19 years in the People's Hospital, Jianshi County, and the state of an illness is not still felt any better, from June, 1977~August through taking this ointment, after three courses of treatment, check earlier that by the X of Jianshi County hospital two lungs are clear, symptom 100% disappears.
(3). beam * *, woman, 45 years old, the worker of Jiangling welfare home, its symptom is cough, chest pain, through Jing Zhou hospital CT examination, find right lung and liver's tumor, respectively be " Lee " big, through 93 years by its treatment after do not feel any better, begin to take this ointment in January, 94, January is after B ultrasonic, X-ray examination, lung and liver's tumor disappear, and symptom is 100% disappearance thereupon.
(4). Qi Jiayuan, the woman, 52 years old, Jingzhou District was checked the cadre of institute.Its symptom is the haematemesis piece, the silk of spitting blood, and film making checks that conclusion is a pulmonary tuberculosis through chaste tree Shashi central hospital, and 96 on JIUYUE are after October 31, Nikkei was taken this ointment in 26, to 96 year, and by X-ray and ultrasound diagnosis, two lungs are clear, and symptom 100% disappears.
Claims (3)
1. treat the sick medicine of pulmonary tuberculosis (pulmonary tuberculosis) for one kind, it is characterized in that: be made up of herbal powder buckwheat Radix Notoginseng, powder Bulbus Lilii, the powder Radix Angelicae Dahuricae, powder Herba Solani Lyrati, powder Fructus Corni, powder Radix Actinodaphnes Cupularis, its percentage by weight accounts for respectively:
Buckwheat Radix Notoginseng: 60%
Bulbus Lilii: 15.5%
The Radix Angelicae Dahuricae: 2%
Herba Solani Lyrati: 13.5%
Fructus Corni: 6%
Radix Actinodaphnes Cupularis: 3%
Total weight percent: 100%.
2: the medicine that treatment pulmonary tuberculosis according to claim 1 (pulmonary tuberculosis) is sick, it is characterized in that: herbal powder buckwheat Radix Notoginseng, powder Bulbus Lilii, the powder Radix Angelicae Dahuricae, powder Herba Solani Lyrati, powder Fructus Corni, powder Radix Actinodaphnes Cupularis Six-element Chinese herbal medicine are 200 orders~220 orders.
3. the medicine that treatment pulmonary tuberculosis according to claim 1 and 2 (pulmonary tuberculosis) is sick, it is characterized in that: in every 4000g medicine, need join adjuvant: Mel: 1000g, crystal sugar: 1000g, white sugar 1000g, change Adeps Sus domestica (or Adeps caprae seu ovis) 1000g, Pancreas Sus domestica (or Pancreas caprae seu ovis): 21 pairs.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96121466A CN1186679A (en) | 1996-12-30 | 1996-12-30 | Medicine for curing pulmonary tuberculosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96121466A CN1186679A (en) | 1996-12-30 | 1996-12-30 | Medicine for curing pulmonary tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1186679A true CN1186679A (en) | 1998-07-08 |
Family
ID=5126915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96121466A Pending CN1186679A (en) | 1996-12-30 | 1996-12-30 | Medicine for curing pulmonary tuberculosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1186679A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071128C (en) * | 1998-12-02 | 2001-09-19 | 衣明兴 | Process for preparing injection to treat pulmonary tuberculosis |
CN1306328C (en) * | 2003-04-24 | 2007-03-21 | 阿尔卑斯电气株式会社 | Semi-transmission type LCD Device and electronic device having same |
WO2009036772A1 (en) | 2007-09-21 | 2009-03-26 | Pharmabrand S.A. | Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
CN101236335B (en) * | 2006-12-20 | 2010-06-23 | 索尼株式会社 | Display device and method of manufacturing the same |
-
1996
- 1996-12-30 CN CN96121466A patent/CN1186679A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071128C (en) * | 1998-12-02 | 2001-09-19 | 衣明兴 | Process for preparing injection to treat pulmonary tuberculosis |
CN1306328C (en) * | 2003-04-24 | 2007-03-21 | 阿尔卑斯电气株式会社 | Semi-transmission type LCD Device and electronic device having same |
CN101236335B (en) * | 2006-12-20 | 2010-06-23 | 索尼株式会社 | Display device and method of manufacturing the same |
WO2009036772A1 (en) | 2007-09-21 | 2009-03-26 | Pharmabrand S.A. | Anti-aids, anti-tumour, immune-system-stimulating herbal composition and production method therefor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101332277A (en) | Preparation method of first-aid liquid for treating whole blood elevation | |
CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
CN103432265A (en) | Traditional Chinese medicinal composition preparation for treating fever in children and preparation method thereof | |
CN1186679A (en) | Medicine for curing pulmonary tuberculosis | |
CN100386106C (en) | Medicine for treating acne and its preparation | |
CN103099914B (en) | Traditional Chinese medicine composition for treating acute pancreatitis | |
CN101829248B (en) | Traditional Chinese medicine for treating goiter | |
CN101036732A (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
CN101204554B (en) | Medicaments composite for stomach illness and preparation method thereof | |
CN101077360B (en) | Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof | |
CN117462620B (en) | A Chinese medicine formula for treating lung cancer, and its preparation method and application | |
CN104189174B (en) | Chinese medicine composition of a kind of relieving cough and moistening lung and preparation method thereof | |
CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
CN100408048C (en) | Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof | |
CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
CN118320028A (en) | Traditional Chinese medicine composition, preparation method and application | |
WO2025015875A1 (en) | Use of flavored nidus vespae pill in preparation of drug for treating lymphadenitis | |
CN1118262A (en) | Compounded composition for cancers | |
CN101933982B (en) | Capsule for treating proctitis | |
CN112933135A (en) | Composition for treating spleen and stomach weakness and application thereof | |
CN100542574C (en) | The medicine of regenerating thigh and preparation technology thereof | |
CN1589830A (en) | Miao nationality medicine for treating enuresis and its compounding method | |
CN103566302A (en) | Traditional Chinese medicine for treating atrophic gastritis | |
CN114652785A (en) | Application for primary cold-dampness stagnation type dysmenorrhea and preparation method thereof | |
CN103211995A (en) | Medicament for treating ovarian cyst |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |